Patently-O

DECEMBER 12, 2022

One company – Intel – is responsible for the majority of applicant-requested suspended prosecution, with 2000+ applicants pending in suspended form. FujiFilm and Lyft are the two other big users, each with 100+ pending cases. Part C suspends examination following the filing of an RCE for up to three-months.

Patent Application 54

Patent Application Patent 54

Bio Law Blog

APRIL 15, 2020

These include favipiravir (Avigan), a flu medication produced by Fujifilm subsidiary Toyama Chemical, and ribavirin, a drug used to fight respiratory syncytial virus (RSV). Both are now undergoing clinical trials for COVID-19.

Copying 40

Copying Designs Design 40

Fish & Richardson Trademark & Copyright Thoughts

FEBRUARY 4, 2021

As of the March 23, 2020 transition, however, all “biological product” applications previously approved under the FD&C Act were “deemed” approved under the PHS Act, and companies can now seek biosimilars and interchangeables of these biological products. As noted above, companies are already taking advantage of these new designations.

Settlement 52

Settlement Litigation Marketing Marketing 52

Fish & Richardson Trademark & Copyright Thoughts

JANUARY 11, 2022

Several other companies have also announced plans to pursue interchangeable status for biosimilar products. Consistent with this, as shown below in Table 2, numerous companies have publicly announced the submission and/or acceptance of new biosimilar BLAs. Stimufend ® (Fresenius Kabi). Neulasta ® (Amgen). pegfilgrastim.

Litigation 52

Litigation Settlement Patent Marketing 52